Loading clinical trials...
Loading clinical trials...
Primary Versus Secondary Internal Limiting Membrane Peeling in Uncomplicated Retinal Detachment
Patients with uncomplicated rhegmatogenous retinal detachment will be recruited. All eyes will underwent 23G PPV with silicon oil tamponade. The eyes will be classified into two groups according to the timing of ILM peeling. Group A, ILM peelin will be performed during the first intervention, while in group B, it will be done at the time of silicon oil extraction.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Sohag Faculty of Medicine
Sohag, Sohag Governorate, Egypt
Start Date
December 15, 2025
Primary Completion Date
December 1, 2026
Completion Date
March 1, 2027
Last Updated
January 16, 2026
100
ESTIMATED participants
Primary ILM peeling
PROCEDURE
Secondary ILM peeling
PROCEDURE
Lead Sponsor
Sohag University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions